The Inaugural John Vane Memorial Symposium on Prostacyclin Science and Pulmonary Vascular Disease was held at the Royal Society in 2006 and was funded by an unrestricted educational grant from United Therapeutics. The aim of the series, which was originally intended to run annually for four years, was to honour the memory of Sir John Vane, FRS, the founder of the William Harvey Research Institute and his discovery of prostacyclin and its analogues including Remodulin.

Since that first meeting, the Symposium has enjoyed continued and growing success and is now established as a leading event in the PAH (Pulmonary Arterial Hypertension) calendar.

The John Vane Memorial Symposium on Prostacyclin Science and Pulmonary Vascular Disease is held each year around the time of Sir John's birthday in March.

What makes JVMS so special?

Hear Professor Brendan Whittle and Professor Chris Thiemermann speak about their experience at JVMS throughout the years.